Ludmila V. Morkovkina

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Dmitry S. Bordin, Dmitrii N. Andreev, Sayar R. Abdulkhakov, Irina N. Voynovan et autres

Background/Objective: Eradication of Helicobacter pylori typically uses acid-suppressing agents plus antimicrobials, but treatment failure may reach 20–30%. Adjunctive rebamipide has been proposed as a strategy to improve treatment outcomes. This study aimed to assess the effectiveness and safety of first-line empirical therapy …

ru, us, es, fr, ie (code pays fourni par la source)

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management

Samuel J. Martínez-Domínguez, Ángel Lanas, Enrique Ceamanos, Irina N. Voynovan et autres

BACKGROUND & AIMS: Evidence on optimal bismuth and antibiotic dosing is limited. We aimed to analyze the effectiveness of bismuth-containing quadruple regimens according to drug dosage. METHODS: This was an analysis of an international, prospective, non-interventional registry on the management of Helicobacter …

es, ru, lt, ua, az, rs, tr, pl, fr (code pays fourni par la source)

107 - UTILIDAD LIMITADA DE LOS DATOS DE RESISTENCIA DE HELICOBACTER PYLORI BASADOS EN LA LITERATURA PARA PREDECIR LA EFICACIA DEL TRATAMIENTO EMPÍRICO DE PRIMERA LÍNEA: INTEGRACIÓN EN EL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR H. PYLORI (HP-EUREG)

Ismail Kirrout, Beatriz Nafría, Ángeles Pérez-Aísa, Bojan Tepes et autres

EFECTIVIDAD DEL USO REPETIDO DE TERAPIAS DE ERRADICACIÓN TRAS UN FRACASO PREVIO: RESULTADOS DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)

Elisa Cantú‐Germano, Leticia Moreira, Ludmila G. Vologzanina, Samuel J. Martínez-Domínguez et autres

P-97 - POSOLOGÍA DE LOS DIFERENTES FÁRMACOS UTILIZADOS EN EL TRATAMIENTO CUÁDRUPLE CON BISMUTO DE PRIMERA LÍNEA Y SU INFLUENCIA EN LA EFECTIVIDAD: RESULTADOS DE 11.000 PACIENTES DEL REGISTRO EUROPEO SOBRE EL MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI (HP-EUREG)

Samuel J. Martínez‐Domínguez, Ángel Lanas, Enrique Ceamanos, Irina N. Voynovan et autres

European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years

Dmitry S. Bordin, Yu.V. Embutnieks, Л. Г. Вологжанина, T. A. Ilchishina et autres

The multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group (EHMSG) is conducted in 27 countries in Europe. The data from the Russian part of the European registry for the management of Helicobacter pylori infection (European Registry on …

ru, fr, ie, es (code pays fourni par la source)

Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii

Dmitry S. Bordin, Yu.V. Embutnieks, Л. Г. Вологжанина, Т А Ильчишина et autres

AIM: European Registry on the management of Helicobacter pylori infection («Hp-EuReg») - a multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group, conducted in 27 European countries in order to evaluate the real clinical practice of diagnosis and …

ru, fr, ie, us, es (code pays fourni par la source)